Vext Science Inc
CNSX:VEXT
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.105
0.375
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CA |
V
|
Vext Science Inc
CNSX:VEXT
|
50.4m CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
992.9B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
541.8B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
271.7B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
212.2B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.1B CHF |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.7T DKK |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
269.1B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
151B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
95.6B EUR |
Loading...
|
Market Distribution
| Min | -9 940 586.9% |
| 30th Percentile | -85.9% |
| Median | -7.8% |
| 70th Percentile | 5.5% |
| Max | 60 777.6% |
Other Profitability Ratios
Vext Science Inc
Glance View
Vext Science, Inc. engages in the cultivation, extraction, and wholesale distribution of cannabis products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-05-13. The firm utilizes a vertical integration business model to execute all aspects of cultivation, extraction, manufacturing (tetrahydrocannabinol (THC) and cannabidiol (CBD) cartridges, concentrates, edibles), retail dispensary, and wholesale distribution of cannabis THC and hemp CBD products. The company provides these management and marketing services in Arizona to two licensed dispensaries. The firm has developed a standard operating procedures (SOPs) to produce a full line of branded flower, Vapen branded THC and CBD distillates, concentrates, extracts, and edibles. The company operates a service business for cannabis cultivation and processing located in the State of Arizona. The firm's products produced under contract are sold through Herbal Wellness Center and Organica Patient Group Medical Marijuana Dispensary, both licensed not-for-profit dispensaries located in Phoenix, Arizona.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Vext Science Inc is -25.3%, which is below its 3-year median of -7.3%.
Over the last 3 years, Vext Science Inc’s Net Margin has decreased from 11.3% to -25.3%. During this period, it reached a low of -43.3% on Dec 31, 2024 and a high of 22.8% on Dec 31, 2022.